Real-world effectiveness and rheumatologist satisfaction with secukinumab in the treatment of patients with axial spondyloarthritis

Volume: 41, Issue: 2, Pages: 471 - 481
Published: Nov 20, 2021
Abstract
To assess the effectiveness of secukinumab in patients with axSpA treated in routine clinical settings in 5 European countries.Retrospective analysis of a cross-sectional survey to assess real-world effectiveness of secukinumab in the management of axSpA and rheumatologist satisfaction with treatment in France, Germany, Italy, Spain and the UK from March to December 2018. Outcomes collected included patient demographics, clinical characteristics...
Paper Details
Title
Real-world effectiveness and rheumatologist satisfaction with secukinumab in the treatment of patients with axial spondyloarthritis
Published Date
Nov 20, 2021
Volume
41
Issue
2
Pages
471 - 481
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.